drugset / Trial / NCT05897151

Continuous Spinal Anesthesia Versus General Anesthesia in Sepsis

NCT05897151

Phase 4 Unknown 110 enrolled Mahmoud Rashad Ahmed
RandomizedParallel-groupOpen-labelTreatment

Summary

The anesthetic efficacy and safety of continuous spinal anesthesia and comparing it with general anesthesia technique in sepsis diagnosed patient.

Timeline

Start
2023-06-10
Primary completion
2023-11-30
Completion
2023-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atracurium Small molecule 0.5 mg/kg
Subject Bupivacaine Other / unclassified 2.5 mg
Subject Fentanyl Other / unclassified 2 ug/kg
Subject Fentanyl Other / unclassified 25 ug
Comparator Propofol Small molecule
Background Continuous spinal anesthesia Unknown 0.01 ug/kg Intravenous